Therapeutic Effects of PUVA Therapy with Percentage Increments for Psoriasis, Evaluated by the Changes of Mpd Values.
- Author:
Chan Woo LEE
1
;
Young Hun KIM
;
Byoung Gun LEE
;
Ki Hoon SONG
;
Ki Ho KIM
Author Information
1. Department of Dermatology, College of Medicine, Dong-A University, Pusan, Korea. imman44@hanmail.net
- Publication Type:Original Article
- Keywords:
PUVA;
MPD;
Percentage increments
- MeSH:
Body Surface Area;
Humans;
Korea;
Methoxsalen;
Psoriasis*;
PUVA Therapy*;
Skin
- From:Korean Journal of Dermatology
2002;40(9):1083-1088
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: The PUVA therapy of psoriasis is a very effective therapeutic modality that combines the action of light and drugs. Generally the conventional PUVA therapy based on patient's skin type is used in Korea. But there are many reported that conventional PUVA therapy is not suitable in several instances including the determination of oral 8-methoxypsoralen(8-MOP) dose, initial and incremental UVA dose and so on. OBJECTIVE: The purpose of this study is to establish a new protocol of PUVA therapy that is photomedically acceptable. METHOD: From 1997 to 2001, twenty psoriasis patients of moderate to severe grade who visited our clinic, were treated with PUVA therapy. Initial UVA dose was the same as MPD of each patient and proportion of weekly incremental UVA dose was 20% added to previous dose. All patients received PUVA therapy twice a week. The 8-MOP dose was determined by body surface area. RESULT: Total of 8 patients were skin type III, and 12 patients were skin type IV. The average of initial MPD in skin type III was 1.75J/cm2(0.5~2.5J/cm2) and skin type IV was 3.25J/cm2(2.5~4.5J/cm2). The average number of treatments to the end of therapy were 13.63(10~16) in skin type III, and 12.5(8~18) in skin type IV. The total cumulative UVA dose was 44.73J/cm2(30~68.2J/cm2) in skin type III, and 67.98J/cm2(31.6~109J/cm2) in skin type IV. CONCLUSION: The excellent effectiveness and safety of our new PUVA protocol have been demonstrated. We conclude that this PUVA protocol is a very effective, safe, and efficient method for the treatment of psoriatic patients.
